Table 1.
Non-cutaneous clinical signs of AFR in dogs
| Clinical sign | Number of animals (% of all reported non-cutaneous AFR) | Strength of evidence |
|---|---|---|
| Diarrhoea [9–19, 22–27, 32–44, 47, 48] | 391–490a (70–88%) | Strong in 36–39a [9–19, 48] Moderate in 151–189a [22–27, 47] Weak in 204–212a [32–44] |
| Vomiting [9, 11, 13–15, 17, 18, 22–27, 33, 34, 40, 42, 43] | 28–115a (5–21%) | Strong in 6–47a [9, 11, 13–15, 17, 18] Moderate in 5–43a [22–27] Weak in 17–25 [33, 34, 40, 42, 43] |
| Increased frequency of defecation [23, 24, 45] | 33 (6%) | Strong in 16 [45] Moderate in 17 [23, 24] |
| Tenesmus [45] | 11 (2%) | Strong in 11 |
| Paroxysmal gluten-sensitive dyskinesia of Border terriers [49] | 5 (1%) | Strong in 2 Weak in 3 |
| Symmetrical lupoid onychodystrophy [50] | 4 (1%) | Strong in 2 Weak in 2 |
| Anaphylaxis [40] | 1 (0.2%) | Weak |
| Conjunctivitis [12] | 1 (0.2%) | Strong |
| Asthma [27] | 1 (0.2%) | Moderate |
| Sneezing [14] | 1 (0.2%) | Strong |
a Minimal and maximal number of dogs, as in some studies, the specific number of dogs showing some of the individual clinical signs was not reported